Literature DB >> 3339372

Neurofilament antigens in acrylamide neuropathy.

B G Gold1, D L Price, J W Griffin, J Rosenfeld, P N Hoffman, N H Sternberger, L A Sternberger.   

Abstract

After repeated exposure, acrylamide (AC) produces degeneration of distal axons. Because neurons whose axons have been injured (e.g. by axotomy) show alterations in their structural and chemical properties, the present study was designed to differentiate the direct effects of AC intoxication from neuronal responses secondary to axonal injury caused by AC. Rats were given AC as either a single high dose (75 mg/kg), or as daily intraperitoneal injections (30 mg/kg, six days per week for four weeks). Dorsal root ganglia of the fifth lumbar level, L5, were examined using a variety of monoclonal antibodies directed against nonphosphorylated (2-135) and phosphorylated (03-44, 06-17, 07-05) epitopes of 145 and 200 kilodalton neurofilament proteins. In control rats, antibody 2-135 stained axons and neuronal cell bodies; antibodies against phosphorylated epitopes of neurofilaments stained only axons distal to the glomerulus. Following chronic AC intoxication, all three antibodies directed against phosphorylated epitopes of neurofilaments (particularly 07-05) demonstrated intense immunoreactivity in 20-30% of neuronal cell bodies. In addition, the glomerular region of these axons was stained. Electron microscopy revealed many chromatolytic cells containing few neurofilaments. In contrast, a single high dose of AC produced no abnormal staining of neuronal cell bodies at a time when slow axonal transport was impaired. Our findings are compared to those observed following axotomy and to those occurring in aluminum-intoxicated rabbits, two experimental disorders in which altered distributions of phosphorylated filaments have been documented.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3339372     DOI: 10.1097/00005072-198803000-00007

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  7 in total

1.  Phosphorylated high molecular weight neurofilament protein in lower motor neurons in amyotrophic lateral sclerosis and other neurodegenerative diseases involving ventral horn cells.

Authors:  G Sobue; Y Hashizume; T Yasuda; E Mukai; T Kumagai; T Mitsuma; J Q Trojanowski
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

2.  Heterogeneous visceral nerve changes in acrylamide intoxication.

Authors:  G L Ferri; S Zareh; M Sbraccia; L Abelli; N Frontali; D Dahl
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

Review 3.  Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration.

Authors:  Rodolphe Perrot; Raphael Berges; Arnaud Bocquet; Joel Eyer
Journal:  Mol Neurobiol       Date:  2008-07-23       Impact factor: 5.590

4.  Somatofugal axonal atrophy precedes development of axonal degeneration in acrylamide neuropathy.

Authors:  B G Gold; J W Griffin; D L Price
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

Review 5.  Probing modifications of the neuronal cytoskeleton.

Authors:  L C Doering
Journal:  Mol Neurobiol       Date:  1993 Fall-Winter       Impact factor: 5.590

6.  Characterization of cytoskeletal and neuronal markers in micromass cultures of rat embryonic midbrain cells.

Authors:  S G Whittaker; J T Wroble; S M Silbernagel; E M Faustman
Journal:  Cell Biol Toxicol       Date:  1993 Oct-Dec       Impact factor: 6.691

7.  Acrylamide alters neurofilament protein gene expression in rat brain.

Authors:  H Endo; S Kittur; M I Sabri
Journal:  Neurochem Res       Date:  1994-07       Impact factor: 3.996

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.